Monitoring in-country medical literature is an essential aspect of pharmacovigilance, providing an early pointer to adverse events in specific populations. Yet traditionally the process is…
Smart analytics applied to real-world data are increasingly enabling companies to track adverse effects, while at the same time identifying opportunities for drug repurposing. ArisGlobal’s…
As well as exposing companies to non-compliance, inefficiency and delays, a manually-maintained pharmacovigilance system master file (PSMF) limits visibility and transparency. Christian Schmitz-Moormann, a senior…
